Orthometrix Inc is primarily active in the healthcare and medical technology industries.

The main competitors of Orthometrix Inc in the market include companies such as Stryker Corporation, Zimmer Biomet Holdings Inc, Medtronic PLC, and Smith & Nephew PLC.

Orthometrix Inc is a renowned company specializing in medical imaging and orthopedic diagnostics. Established in [year], Orthometrix has gained significant recognition for its innovative products and services. With a focus on advanced technology and patient care, the company has been at the forefront of revolutionizing orthopedic diagnosis. Orthometrix has a rich history of developing cutting-edge imaging solutions that aid in the accurate assessment of musculoskeletal conditions. Their commitment to excellence and continuous research has positioned Orthometrix as a leading provider in the field. With a strong presence in the healthcare industry, Orthometrix Inc continues to shape the future of diagnostic imaging for enhanced patient outcomes.

Orthometrix Inc, a renowned company in the stock market, has achieved several significant milestones throughout its journey. The company has successfully developed and introduced innovative medical technologies and solutions, gaining recognition in the healthcare industry. Orthometrix Inc has consistently demonstrated excellence in research and development, leading to groundbreaking advancements in orthopedic diagnostics and treatments. Additionally, the company has established strategic partnerships with leading medical institutions, fostering collaborations and driving further achievements. Orthometrix Inc's commitment to enhancing patient care and improving medical outcomes has made it a trusted and respected name in the industry, solidifying its position as a market leader.

Orthometrix Inc is primarily present in the United States.

Orthometrix Inc represents a strong set of values and a clear corporate philosophy. The company is committed to delivering exceptional quality products and services to meet the needs of its customers. Orthometrix Inc prioritizes innovation, aiming to constantly improve and provide cutting-edge solutions. With a focus on customer satisfaction, the company emphasizes building long-term relationships and delivering value. Orthometrix Inc also values integrity in all aspects of its operations, ensuring honesty and transparency. By combining these values with a forward-thinking approach, Orthometrix Inc seeks to establish itself as a reliable and trusted player in the industry.

Converted at the current exchange rate, the Orthometrix share trades at 0,00 EUR (0,00 USD).

Orthometrix Inc. is a leading company in the field of biomedical engineering and has been the heart of the orthopedic industry since its founding in 1979. Based in Florida, it focuses on research, development, manufacturing, and distribution of medical diagnostic and treatment devices. The company employs a network of technicians, doctors, and scientists who ensure that the quality of the products always remains at the highest level. The business strategy of Orthometrix is aimed at developing innovative products and solutions for the orthopedic industry that improve the lives of patients. Orthometrix has four key business areas. The first business area is the nerve stimulation system, which is used for pain relief in patients. This is an electronic device that inhibits the stimulation of the painful nerves by emitting electrical impulses. Orthometrix's second business area is the analysis of musculoskeletal disorders. Various devices are used here to measure the strength, flexibility, and mobility of bones and joints. As a result of the analysis, the system provides information about possible injuries or diseases in these areas. This system is very useful for patients who have problems with their spine or joints. The third business area is heat and cold treatment. Orthometrix has developed a range of products for heat and cold treatment, which are used for pain relief and inflammation reduction. These include cold and hot compresses, heat pads and pillows, and cold packs. Finally, with its fourth business area, Orthometrix offers a wide range of orthopedic devices. These include braces and bandages that are used for support, healing, or prevention of disease progression. The products in this segment of Orthometrix include hip joint and knee orthosis equipment as well as shin splint supports. Orthometrix employs a vertically integrated strategy from development to sales in order to operate successfully in the market. However, the company also aims to constantly expand its product range and adapt to a growing market. Orthometrix specializes in the requirements of doctors and patients and understands the local and regional market needs of its customers in every country where it distributes its products. To promote the success of its products, Orthometrix has established a direct presence in various countries, including Europe, Asia, and North and South America. Orthometrix's goal is to further expand its reach to provide more access to a larger customer base and increase its market share in the biomedical engineering industry. Through continuous innovation, research, and development of new products, Orthometrix will continue to play a leading role in the orthopedic industry.

Liikevaihtoa ei voida laskea Orthometrix:lle tällä hetkellä.

Voittoa ei voida laskea Orthometrix:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Orthometrix:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Orthometrix:lle tällä hetkellä.

Orthometrix:n Eulpool-laatuscore on 2/10.

Orthometrix:n ISIN on US68750M1009. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Orthometrix:n WKN on 899107. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Orthometrix:n ticker on OMRX. Tämä pörssinoteeraus käytetään Orthometrix-osakkeiden kauppaan pörssissä.

Orthometrix maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Orthometrix kuuluu sektoriin 'Terveydenhuolto'.

Orthometrix:n osingot jaetaan valuutassa USD.